Use access key #2 to skip to page content.
$2.89 0.25 (9.47%)
7/8/2008 4:00 PM

MannKind Corp (MNKD)

CAPS Rating:
*

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

0

Avatar KipLargo (79.97) Submitted: 5/12/08 11:19 AM : Underperform Start Price: $2.33 MNKD Score: -28.06

Sorry MannKind, you will probably be out of business in less than five years. Your inhaled insulin will never totally work out and you'll never get the money you burned creating it back.

Report this Post Replies: 0 | Reply

Featured Broker Partners